NIKA — Nika Pharmaceuticals Cashflow Statement
0.000.00%
- $291.15m
- $291.43m
Annual cashflow statement for Nika Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.009 | -0.015 | -3.18 | -0.065 | -0.096 |
| Non-Cash Items | — | 0 | 3.15 | 0 | -0.043 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | — | — | — | -0.016 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.018 | -0.029 | -0.067 | -0.13 | -0.31 |
| Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 0 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.021 | 0.027 | 0.068 | 0.167 | 0.275 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.002 | -0.001 | 0 | 0.019 | -0.018 |